You just read:

Blueprint Medicines to Present Preclinical Data and Provide Enrollment Updates for Phase 1 Clinical Trial for BLU-285 in Advanced Systemic Mastocytosis at ECNM Annual Meeting 2016

News provided by

Blueprint Medicines

28 Oct, 2016, 08:30 ET